
Rosen Law Firm Encourages Revance Therapeutics, Inc. (NASDAQ: RVNC) Shareholders to Learn About Their Rights and Options
Class Action Lawsuit Filed Against Revance Therapeutics: What Does It Mean for Investors and the Industry? In a recent development, a class action lawsuit has been filed against Revance Therapeutics, Inc. (RVNC), a biotechnology company specializing in the development, manufacturing, and commercialization of neuromodulators for aesthetic and therapeutic indications. The lawsuit, filed on behalf of…